Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Vomiting × alizapride × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 1 Neoplasms 1 Nausea 1 Breast Neoplasms 1

Interventions

Aprepitant 8 Palonosetron 5 Dexamethasone 5 Granisetron 3 fosaprepitant 2 dexamethasone 21-phosphate 2 Tropisetron 2 Ondansetron 2 Metoclopramide 2 Calcium Dobesilate 2 ramosetron 1 naldemedine 1 gamma-Aminobutyric Acid 1 dolasetron 1 dexamethasone acetate 1 alizapride 1 Tablets 1 Spinal Puncture 1 Saline Solution 1 Population Groups 1 Olanzapine 1 Myelography 1 Duration of Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01636947 2018-09-25

KMEC

Merck Sharp & Dohme LLC

Phase 4 Completed

494 enrolled 14 charts

Nausea, Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡